Xiao-bing H. Chen - Publications

Tumor-microenvironment-mediated immune escape drives trastuzumab resistance in HER2-positive gastric cancer.

Journal: Gastroenterology report

Published: December 19, 2025

Molecular subtyping-guided precision therapy for ESCC: biomarker-driven strategies and clinical translation pathways.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 09, 2025

Current research status and challenges of neoadjuvant immunotherapy for Esophageal squamous cell carcinoma.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: November 24, 2025

Ifebemtinib and paclitaxel synergistically inhibit the proliferation and metastasis of TNBC by blocking PI3K/Akt pathway through LSD1/PIK3IP1 axis.

Journal: Scientific reports

Published: July 16, 2025

The Chemical Profiling and Immunological Activity of Polysaccharides from the Rhizome of Imperata cylindrica Using Hot Water Extraction.

Journal: Molecules (Basel, Switzerland)

Published: April 22, 2025

NAT10 Increases Lysosomal Acidification to Promote Esophageal Cancer Metastasis via ac4C Acetylation of ATP6V0E1 mRNA.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 15, 2025

Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug Resistance.

Journal: Journal of medicinal chemistry

Published: October 19, 2024

Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer.

Journal: Journal of medicinal chemistry

Published: September 12, 2024

Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway.

Journal: Recent patents on anti-cancer drug discovery

Published: June 09, 2024

Degraders in epigenetic therapy: PROTACs and beyond.

Journal: Theranostics

Published: November 23, 2023

HER2+ advanced gastric cancer: Current state and opportunities (Review).

Journal: International journal of oncology

Published: October 13, 2023

Utilizing natural products as new E3 ligase ligands for targeted protein degradation.

Journal: Chinese journal of natural medicines

Published: September 23, 2023